QualifyHQ Logo

Enso

ENYO Pharma is a clinical-stage biopharmaceutical company developing innovative therapeutics based on fibrolytic and anti-inflammatory properties for diseases with impaired kidney function.The company is conducting Phase 2 trials with its lead compound Vonafexor in Chronic Kidney Diseases (CKD) and rare kidney disease such as Alport syndrome.

Bunaithe

2014

Ioncam

$2.5M - $5.0M

Maoiniú

$108.8M

Féach ar chuideachtaí cosúla

Qualify this Company in

minutes

Cé go gcuireann uirlisí eile am amú, cabhraímid leat cuideachtaí níos oiriúnaí a cháiliú i gceann nóiméad, ionas go bhfanann do phíblíne folláin, go bhfanann d'fhoireann táirgiúil, agus go mbogann do mhargaí níos tapúla.

Start free trial

Tosaigh Triail Saor in Aisce 7-Day